EXANE DERIVATIVES - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 176 filers reported holding QIAGEN NV in Q1 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of QIAGEN NV
ValueSharesWeighting
Q4 2016$442,118,000
+34.6%
15,720
+2225.4%
0.09%
+107.1%
Q3 2015$328,514,000
+14.5%
676
-5.6%
0.04%
+35.5%
Q2 2015$286,869,000
-37.1%
716
-34.9%
0.03%
-38.0%
Q1 2015$456,203,000
+105.1%
1,100
-10.4%
0.05%
+66.7%
Q4 2014$222,447,0001,2280.03%
Other shareholders
QIAGEN NV shareholders Q1 2015
NameSharesValueWeighting ↓
Hardman Johnston Global Advisors LLC 6,178,402$170,833,00011.32%
Tikvah Management LLC 369,425$10,215,0005.35%
BLUE JAY CAPITAL MANAGEMENT, LLC 360,000$9,954,0003.36%
Opus Point Partners Management, LLC 160,000$4,424,0002.92%
Exane Asset Management 106,238$2,910,304,0001.76%
Douglas C. Lane & Associates, Inc. 1,918,338$53,042,0001.44%
Granahan Investment Management 1,051,000$29,060,0001.00%
CRAMER ROSENTHAL MCGLYNN LLC 2,285,569$63,196,0000.95%
Sivik Global Healthcare LLC 70,000$1,936,0000.92%
PURA VIDA INVESTMENTS, LLC 78,668$2,175,0000.92%
View complete list of QIAGEN NV shareholders